¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"High Technol Law J"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • law of weights and measures
    °è·®¹ý
  • medical service law
    ÀÇ·á¹ý
  • public health law
    °øÁߺ¸°Ç¹ý
  • periodic law
    ÁÖ±âÀ²
  • pharmaceutical affairs law
    ¾à»ç¹ý
  • surface law
    üǥ¸é¹ýÄ¢
  • universal gas law
    ÀϹݱâü¹ýÄ¢
  • high altitude
    °íÁö-, °í¼Ò-
  • high altitude illness
    °í¼Òº´
  • high altitude polycythemia
    ³ôÀº°÷ÀûÇ÷±¸Áõ°¡Áõ
  • high altitude pulmonary edema
    °íÁö´ëÆóºÎÁ¾
  • high density lipoprotein
    °í¹ÐµµÁöÁú´Ü¹éÁú
  • high dose rate
    °í¼±·®·ü
  • high dose rate intraluminal radiotherapy
    °í¼±·®·ü°ü³»¹æ»ç¼±Ä¡·á
  • high dose tolerance
    Ç׿ø°ú·®Çã¿ë
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • periodic law
    ÁÖ±âÀ²
  • pharmaceutical affairs law
    ¾à»ç¹ý
  • public health law
    °øÁߺ¸°Ç¹ý
  • surface law
    üǥ¸é¹ýÄ¢
  • universal gas law
    ÀϹݱâü¹ýÄ¢
  • high power application
    °íÃâ·ÂÀû¿ë
  • high spatial frequency algorithm
    °í°ø°£Á֯ļö¿¬»ê
  • high energy bond
    °í¿¡³ÊÁö°áÇÕ
  • high speed core cut biopsy
    °í¼ÓÁ߽ɻý°Ë
  • high frequency current
    °íÁÖÆÄÀü·ù
  • high polymer chemistry
    °íºÐÀÚÈ­ÇÐ
  • high-performance liquid chromatography
    °íÀÛÀ§¾×üũ·Î¸¶Åä±×·¡ÇÇ
  • high-pressure liquid chromatography
    °í¾Ð·Â¾×üũ·Î¸¶Åä±×·¡ÇÇ
  • high-threshold cell
    °í¹®Åΰª¼¼Æ÷
  • high forceps delivery
    °íÀ§Áý°ÔºÐ¸¸¼ú
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Snells law
    ½º³Ú¹ýÄ¢
  • Vant Hoffs law
    ¹ÝÆ® È£ÇÁ ¹ýÄ¢
  • gas law
    ±âü¹ýÄ¢(Ѩô÷ÛööÎ).
  • group displacement law
    Áý´Üº¯À§¹ýÄ¢(ÊÙËÒ ËôËÑ̬).
  • pharmacist law
    ¾àÁ¦»ç¹ý(ËâÌ¡Ë×ËÑ).
  • public health law
    º¸°Ç¹ý(ËÓ˧ËÑ).
  • quotient law
    »ó¹ýÄ¢(Ë×ËÑ̬).
  • reciprocity law
    »ó¹Ý¹ýÄ¢(ßÓÚãÛööÎ).
  • HDL (High-density lipoproteins)
    °í¹ÐµµÁö´Ü¹éÁú(ÍÔÚËÓøò·Ó±ÛÜòõ)
  • High energy phosphate
    °í¿¡³ÊÁöÀλê
  • High intensity proton flow
    °í°­µµ ¾çÀÚ À¯µ¿
  • High-density lipoprotein = HDL
    °í¹ÐµµÁö´Ü¹éÁú(ÍÔÚËÓøò·Ó±ÛÜòõ)
  • High-molecular-weight kininogen
    °íºÐÀÚ·®Å°´Ï³ëÁø
  • High-threshold cells
    °í¿ªÄ¡¼¼Æ÷(ÍÔ ö·á¬øà)
  • high altitude
    °í¼Ò
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • law of contrary innervation
    ¹Ý´ë·ÂÁö¹è(ÚãÓßæ³ò¨ÛÕ)ÀÇ ¹ýÄ¢.
  • law of definite proportions
    Á¤ºñ·Ê(ïáÝïçÓ)ÀÇ ¹ýÄ¢.
  • law of denervation
    Å»½Å°æ(÷­ãêÌè)ÀÇ ¹ýÄ¢, ½Å°æÀýÁ¦ÀÇ ¹ýÄ¢.
  • law of dominance
    ¿ì¿­(éÐæë)ÀÇ ¹ýÄ¢.
  • law of forward conduction
    Àü¹æÀüµµ(îñÛ°îîÓô)ÀÇ ¹ýÄ¢.
  • law of great numbers
    ´ë¼ö(ÓÞâ¦)ÀÇ ¹ýÄ¢.
  • law of heart
    ½ÉÀå(ãýíô)¹ýÄ¢(ÛööÎ).
  • law of independent unit character
    ÇüÁúµ¶¸³À¯Àü(û¡òõÔ¼í¡ë¶îî)ÀÇ ¹ýÄ¢.
  • law of mass action
    Áú·®ÀÛ¿ë(òõåÖíÂéÄ) ¹ýÄ¢.
  • law of octaves
    ¿ÁŸ¾ÆºêÀÇ ¹ýÄ¢.
  • law of participation
    °ü¿©(μæ¨)ÀÇ ¹ýÄ¢.
  • law of photochemical equivalent
    ±¤È­Çд緮(ÎÃûùùÊÓ×åÖ)ÀÇ ¹ýÄ¢.
  • law of prophylaxis for infectious diseases
    Àü¿°º´¿¹¹æ¹ý(ËøËçËÓËçËÑËÑ).
  • law of reciprocity
    »óÈ£(Ë×Ì´)¹ýÄ¢.
  • law of reflection
    ¹Ý»ç(ÚãÞÒ)ÀÇ ¹ýÄ¢.
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • high-speed sedimentation equilibrium
    "°í¼Ó ħ°­ÆòÇü(ÍÔáÜöØË½øÁû¬)(¹ý,Ûö)"
  • high-temperature protection regulon
    °í¿Âº¸È£(ÍÔè®ÜÁûÞ) ·¹±Ö·Ð
  • high-temperature-short-time method
    °í¿Â ´Ü½Ã°£¹ý(ÍÔè®Ó­ãÁÊàÛö)
  • high-voltage electrophoresis
    °íÀü¾Ð Àü±â¿µµ¿(ÍÔï³äâï³Ñ¨ç¶ÔÑ)
  • very high-density lipoprotein
    Ãʰí¹Ðµµ(õ±ÍÔÚËÓø) ÁöÁú´Ü¹éÁú(ò·òõÓ±ÛÜòõ)
  • very high-lipid lipoprotein
    ÃʰíÁöÁú(õ±ÍÔò·òõ) ÁöÁú´Ü¹éÁú(ò·òõÓ±ÛÜòõ)
  • Beer-Lambert law
    ºñ¾î-¶÷º£¸£ ¹ýÄ¢(ÛööÎ)
  • Beer's law
    ºñ¾î ¹ýÄ¢(ÛööÎ)
  • biogenetic law
    »ý¹°¹ß»ý¹ýÄ¢(ßæÚªÛ¡ßæÛööÎ)
  • Bouguer's law
    ºÎ°Ô ¹ýÄ¢(ÛööÎ)
  • Bronsted catalysis law
    ºê·Ð½ºÅ×µå Ã˸ŹýÄ¢(õºØÚÛööÎ)
  • Clausius'law
    "Ŭ·Î½Ã¿ì½º ¹ýÄ¢(ÛööÎ), (ÔÒ) aphorism of Clausius"
  • distribution law
    "ºÐÆ÷ ¹ýÄ¢(ÝÂøÖÛööÎ), (ÔÒ) partition law"
  • Draper's law
    µå·¡ÆÛ ¹ýÄ¢(ÛööÎ) (ÔÒ) first law of photochemistry
  • Fick's first law
    ÇÈ Á¦ 1 ¹ýÄ¢(ÛööÎ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • high resolution computed tomography [=HRCT]
    °íÇØ»óÀü»êÈ­´ÜÃþÃÔ¿µ¼ú
  • high risk group
    °íÀ§Çèµµ±º
  • high signal
    °í½ÅÈ£
  • high signal intensity
    °í½ÅÈ£°­µµ
  • high spatial frequency algorithm
    °í°ø°£Á֯ļö¿¬»ê
  • high speed
    °í¼ÓÀÇ
  • high speed core cut biopsy
    °í¼ÓÁ߽ɻý°Ë
  • high velocity signal loss
    °í¼Óµµ½ÅÈ£¼Ò½Ç
  • high voltage radiography
    °í¾ÐÃÔ¿µ¼ú
  • high voltage radiography
    °íÀü¾ÐÃÔ¿µ¼ú
  • HRCT [=high resolution comnputed tomography]
    °íÇØ»óÀü»êÈ­´ÜÃþÃÔ¿µ¼ú
  • paramagnetic high susceptibility
    »óÀÚ¼º°íÀÚÈ­À²
  • pseudodiastole in high intensity proton flow
    °í°­µµ¾çÀÚÀ¯µ¿¿¡¼­ À§À̿ϱâ
  • super high field MR scanner
    ÃʰíÀÚÀåMR½ºÄ³³Ê, ÃʰíÀÚÀåÀÚ±â°ø¸í½ºÄ³³Ê
  • ultra high field MR scanner
    ÃʰíÀÚÀåÀÚ±â°ø¸í½ºÄ³³Ê
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
HT Hashimoto thyroiditis; hearing test; hearing threshold; heart; heart transplantation, heart transpla...
AAPL American Academy of Psychiatry and the Law
ASLM American Society of Law and Medicine
DALE Drug Abuse Law Enforcement
LAW left atrial wall
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
H High
HA High
HF High
HR High
HAD High Alcohol Drinking
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • Wallerian law
    ¿Ð·¯ º¯¼º ¹ýÄ¢
  • Walton's law
    ¿ÐưÀÇ ¹ýÄ¢
    µ¿ÀǾî=law of reci
  • Zettnow's stain ¼¼±Õ Æí¸ð¸¦ ¿°»öÇÏ´Â ¹æ¹ý

    Zeune's law ¸ÍÀÎÀÇ ¼ö´Â Àûµµ¿¡ °¡±î¿î ¿­´ëÁö¹æ¿¡¼­ Áõ°¡ÇÑ´Ù.

    zidovudin

    ÁöµµºÎµò
    µ¿ÀǾî=azidothymidine.
  • admixed high-copper alloy
    È¥ÇÕÇü °íµ¿ÇÕ±Ý
    °íµ¿ÇÕ±ÝÀÇ °¡Àå ¿À·¡µÈ ÇüÅ·μ­ Àº, ÁÖ¼®, 6% ÀÌÇÏÀÇ ±¸¸®¸¦ ÇÔÀ¯ÇÑ Àç·¡Çü Àúµ¿ÇԱݰú ´ë°Ô ±¸¸®°¡ ¸¹Àº Àº-±¸¸® °øÁ¤ ÇÕ±ÝÀÇ µÎ °¡Áö ºÐ¸»À» È¥ÇÕÇÏ¿© ±¸¸®ÀÇ ÃÑ·®À» Áõ°¡½ÃŲ °ÍÀÌ´Ù. Àúµ¿ Àç·¡Çü ÇÕ±ÝÀº Àý»èÇüÀÌ¸ç °íµ¿ÇÕ±ÝÀº ±¸»óÇüÀ̾ °á°úÀûÀ¸·Î Àý»èÇü°ú ±¸»óÇüÀÌ È¥ÇÕµÈ °ÍÀÌ´Ù.
  • high arched
    ³ôÀº ±¸°³±Ã
  • high cellular component
    °í¼¼Æ÷ ±¸¼º ¼ººÐ
  • high condylectomy
    °í °úµÎ ÀýÁ¦¼ú, »ó°úµÎ ÀýÁ¦¼ú
    »ó,ÇÏ¾Ç °úµÎÀÇ ÀϺκи¸À» ¿Ü°úÀûÀ¸·Î Á¦°ÅÇÏ´Â °Í.
  • high copper amalgam
    °íµ¿ ¾Æ¸»°¨
    ¾Æ¸»°¨ Çձݿ¡¼­ ±¸¸®ÀÇ ºñ°¡ ³ôÀº °Í.
  • high dose tolerance
    °í¿ª ¿ªÄ¡
  • high electron density
    °íÀüÀÚ ¹Ðµµ
    ÀüÀÚµéÀÇ ¹Ðµµ°¡ ³ôÀº °÷.
  • high energy phosphate bond
    °í¿¡³ÊÁö ÀÎ»ê °áÇÕ
    ÀÎ»ê °áÇÕ ÇüŰ¡ ³ôÀº ¿¡³ÊÁö·Î ÀÌ·ç¾îÁø »óÅÂ. ÀÌ °áÇÕÀº ¾Æ³×³ë½Å »ïÀλê. Æ÷½ºÆ÷Å©·¹¾ÆÆ¾. ´ç ´ë»çÀÇ Áß°£»ê¹° µî¿¡ Á¸ÀçÇÑ´Ù.
  • high energy radiation
    °í¿¡³ÊÁö ¹æ»ç¼±
    ³ôÀº ¿¡³ÊÁöÀÇ ¹æ»ç¼±À» ¹æÃâÇÏ´Â °Í.
  • high fever
    °í¿­
    ³ôÀº ¿­.
  • high frequency
    °íºóµµ, °íÁÖÆÄ
    ¿¡³ÊÁö°¡ ÀÚÁÖ ¹ß»ýµÇ´Â °Í. ºóµµ°¡ ³ôÀº °Í.
  • high frequency heating
    °íÁÖÆÄ °¡¿­
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
high blood pressure <cardiology> Persistently high arterial blood pressure. Hypertension may have no known cause (essential or idiopathic hypertension) or be associated with other primary diseases (secondary hypertension).
This condition is considered a risk factor for the development of heart disease, peripheral vascular disease, stroke and kidney disease.
(29 Sep 1997)
high blood triglyceride <biochemistry> Elevation of triglycerides, a fatty substance found in the bloodstream. Normal triglyceride blood levels should be 10-150 milligrams per decilitre. Elevations of the triglyceride level (particularly in association with elevated cholesterol) have been correlated with the development of atherosclerosis, the underlying cause of heart disease and stroke.
Origin: Gr. Haima = blood
(27 Sep 1997)
high-bred Bred in high life; of pure blood.
Source: Websters Dictionary
(01 Mar 1998)
high-calorie diet A diet containing upward of 4,000 calories per day.
(05 Mar 2000)
high convex The segment of a sphere of short radius.
(05 Mar 2000)
high density lipoprotein <biochemistry> These lipoproteins acts to carry cholesterol in the bloodstream.
Raised high density lipoprotein levels have been correlated with a lower risk for heart disease. Less than 35 mg/dl is considered a positive risk factor for coronary artery disease, over 60 mg/dl is considered a negative risk factor (reduces your risk of heart disease).
Recent studies show a low high density lipoprotein level is the strongest predictor of cardiovascular death in women.
Acronym: HDL
(18 Nov 1997)
high dose tolerance The induction of tolerance by exposure to high doses of antigen.
(05 Mar 2000)
high-egg-passage vaccine Living Flury strain rabies virus at the 180th to 190th level egg passage (embryonate eggs), used for vaccination of cattle and cats, low-egg-passage (LEP) vaccine: at the 40th to 50th passage level, containing 103 to 104 mouse LD50; nonpathogenic in dogs but retains some pathogenicity for cattle and cats.
(05 Mar 2000)
high endothelial postcapillary venules Venule's in the lymph nodes, tonsils, and Peyer's patches that have a high-walled endothelium through which blood lymphocytes migrate into the lymphatic parenchyma.
(05 Mar 2000)
high enema An enema instilled high up into the colon.
Synonym: enteroclysis.
(05 Mar 2000)
high energy bond <chemistry> Chemical bonds that release more than 25kJ/mol on hydrolysis: their importance is that the energy can be used to transfer the hydrolysed residue to another compound. The risk in using the term is that students may think the bond itself is different in some way, whereas it is the compound that matters. Hydrolysis of creatine phosphate yields 42.7kJ/mol, of phosphoenolpyruvate, 53.2, ATP to ADP, 30.5: the latter is important because it shows that energetically the hydrolysis of creatine phosphate will suffice to reconstitute ATP, hence the use of creatine phosphate in muscle.
(18 Nov 1997)
high energy compounds Classically, a group of phosphoric esters whose hydrolysis takes place with a standard free energy change of -5 to -15 kcal/mol (or, -20 to -63 kJ/mol) (in contrast to -1 to -4 kcal/mol or, -4 to -17 kJ/mol) for simple phosphoric esters like glucose-6-phosphate or alpha-glycerophosphates), thus being capable of driving energy-consuming reactions in living cells or reconstituted cell-free systems; adenosine 5'-triphosphate, with respect to the beta-and gamma-phosphates, is the best known and is regarded as the immediate energy source for most metabolic syntheses. The general types are acid anhydrides, phosphoric esters of enols, phosphamic acid (R-NH-PO3H2) derivatives, acyl thioesters (e.g., of coenzyme A), sulfonium compound's (R3-S+), and aminoacyl esters of ribosyl moieties.
See: high energy phosphates.
(05 Mar 2000)
high energy particle generating unit A machine capable of providing highly energised radiation for the purposes of radiotherapy treatment.
(16 Dec 1997)
high energy phosphate bond See: high energy phosphates.
(05 Mar 2000)
high energy phosphates Those phosphate's that, on hydrolysis, yield an unusually large amount of energy; e.g., nucleotide polyphosphates such as ATP, enol phosphate's such as phosphoenolpyruvate.
See: high energy compounds.
Synonym: energy-rich phosphates.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • civil law
    ¹Î¹ý;¹Î»ç¹ý;(±¹Á¦¹ý¿¡ ´ëÇÏ¿©)±¹³»¹ý;·Î¸¶¹ý ) V
  • club law
    Æø·Â;Æø·ÂÁÖÀÇ
  • commercial law
    »ó¹ý
  • common law
    °ü½À¹ý;ºÒ¹®À²
  • common-law
    °ü½À¹ýÀÇ;°ü½À¹ý»óÀÇ
  • common-law marriage
    °ü½À¹ý È¥ÀÎ;³»¿¬ °ü°è
  • common-law wife
    ³»¿¬ÀÇ Ã³
  • commutative law
    ±³È¯ ¹ýÄ¢
  • company law
    ȸ»ç¹ý
  • corporation law
    ȸ»ç¹ý
  • counselor-at-law
    º¯È£»ç
  • cousin-in-law
    »çÃÌÀÇ ³²Æí(¾Æ³»)(»çÃÌ ¸ÅºÎ.»çÃÌ Ã³³²µî)
  • criminal law
    Çü¹ý ¹ý
  • crown law
    Çü¹ý no)
  • dietary law
    (À¯´ë±³)À½½Ä ±Ý±â(µÅÁö °í±â µîÀ» ¸ÔÁö ¾Ê´Â ÀÏ)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á